NCT07132190View on ClinicalTrials.gov

Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Brain Metastases, AdultBrain Tumor - MetastaticBrain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases From Extra-cranial Solid Tumors
Interventions
RADIATION

Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV

Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV

Trial Locations (1)

02115

Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Varian, a Siemens Healthineers Company

INDUSTRY

lead

Ayal A. Aizer, MD

OTHER

NCT07132190 - Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction | Biotech Hunter | Biotech Hunter